Cargando…

New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer

The clinicopathological importance of the Ki-67 labeling index (LI) in breast cancer has been studied intensely; however, its prognostic significance in triple-negative breast cancer (TNBC) is unclear. We aimed to determine the optimal Ki-67 cut-off point to demonstrate its prognostic relevance for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Shuang, He, Zhi-Xian, Yu, Ke-Da, Yang, Wen-Tao, Shao, Zhi-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029745/ https://www.ncbi.nlm.nih.gov/pubmed/27050075 http://dx.doi.org/10.18632/oncotarget.8531

Ejemplares similares

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
por: Wu, Qiang, et al.
Publicado: (2019)

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin
por: Wang, Ruo-Xi, et al.
Publicado: (2016)

A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
por: Huang, Liang, et al.
Publicado: (2013)

Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
por: Meng, Yu, et al.
Publicado: (2022)

Ki-67 labeling index as a prognostic marker in advanced stomach cancer
por: Seo, Sang Hyuk, et al.
Publicado: (2019)

Histopathological Spectrum of Meningiomas with Emphasis on Prognostic Role of Ki67 Labelling Index
por: Solanke, Girish, et al.
Publicado: (2020)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

The prognostic relevance of p53 and Ki-67 to chemotherapy sensitivity and prognosis in triple-negative breast cancer
por: Zhang, Guojing, et al.
Publicado: (2021)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas
por: Menger, Richard, et al.
Publicado: (2017)

An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma
por: Du, Ningfang, et al.
Publicado: (2023)

Association of Ki-67 Labelling Index and IL-17A with Pituitary Adenoma
por: Glebauskiene, Brigita, et al.
Publicado: (2018)

Spectral CT imaging parameters and Ki-67 labeling index in lung adenocarcinoma
por: Chen, Mailin, et al.
Publicado: (2020)

Clinicopathological Profile of Primary Hyperparathyroidism with Special Reference to Ki-67 Labelling Index
por: Thanveer, Azhar S., et al.
Publicado: (2023)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Prognostic usefulness of a modified risk model for solitary fibrous tumor that includes the Ki-67 labeling index
por: Sugita, Shintaro, et al.
Publicado: (2022)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance
por: Arafah, Maria A, et al.
Publicado: (2021)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis
por: Liu, Qixin, et al.
Publicado: (2021)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population
por: Theresia, Emilia, et al.
Publicado: (2020)

Relationship Between Ultrasound Features and Ki-67 Labeling Index of Soft Tissue Sarcoma
por: Wang, Pingping, et al.
Publicado: (2021)

IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma
por: Zeng, Ailiang, et al.
Publicado: (2015)

Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women
por: Hao, Shuang, et al.
Publicado: (2015)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
por: Jeong, Tae-Dong, et al.
Publicado: (2016)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
por: Pergolini, I., et al.
Publicado: (2019)

Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions
por: Kubouchi, Koichi, et al.
Publicado: (2020)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas
por: Mastronardi, Luciano, et al.
Publicado: (2001)

Ki-67 labeling index affects tumor infiltration patterns of lung squamous cell carcinoma
por: MASUDA, DAISUKE, et al.
Publicado: (2015)

Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma
por: GADBAIL, Amol Ramchandra, et al.
Publicado: (2021)

Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas
por: Morizawa, Yosuke, et al.
Publicado: (2016)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67
por: Kashiwagi, Shinichiro, et al.
Publicado: (2011)

The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
por: Yin, Liu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vvk2sm3sbrvne44rs7iursecos